HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metal-dependent inhibition of HIV-1 integrase.

Abstract
Human immunodeficiency virus type 1 integrase (HIV-1 IN) is an essential enzyme for effective viral replication. Therefore, IN inhibitors are being sought for chemotherapy against AIDS. We had previously identified a series of salicylhydrazides as potent inhibitors of IN in vitro (Neamati, N.; et al. J. Med. Chem. 1998, 41, 3202-3209.). Herein, we report the design, synthesis, and antiviral activity of three novel mercaptosalicylhydrazide (MSH) derivatives. MSHs were effective against the IN catalytic core domain and inhibited IN binding to HIV LTR DNA. They also inhibited catalytic activities of IN in IN-DNA preassembled complexes. Site-directed mutagenesis and molecular modeling studies suggest that MSHs bind to cysteine 65 and chelate Mg(2+) at the active site of HIV-1 IN. Contrary to salicylhydrazides, the MSHs are 300-fold less cytotoxic and exhibit antiviral activity. They are also active in Mg(2+)-based assays, while IN inhibition by salicylhydrazides is strictly Mn(2+)-dependent. Additionally, in target and cell-based assays, the MSHs have no detectable effect on other retroviral targets, including reverse transcriptase, protease, and virus attachment, and exhibit no detectable activity against human topoisomerases I and II at concentrations that effectively inhibit IN. These data suggest that MSHs are selective inhibitors of HIV-1 IN and may serve as leads for antiviral therapeutics.
AuthorsNouri Neamati, Zhaiwei Lin, Rajeshri G Karki, Ann Orr, Kiriana Cowansage, Dirk Strumberg, Godwin C G Pais, Johannes H Voigt, Marc C Nicklaus, Heather E Winslow, He Zhao, Jim A Turpin, Jizu Yi, Anna Marie Skalka, Terrence R Burke Jr, Yves Pommier
JournalJournal of medicinal chemistry (J Med Chem) Vol. 45 Issue 26 Pg. 5661-70 (Dec 19 2002) ISSN: 0022-2623 [Print] United States
PMID12477350 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Cations, Divalent
  • Chelating Agents
  • HIV Integrase Inhibitors
  • Hydrazines
  • Salicylates
  • Sulfhydryl Compounds
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • Manganese
  • DNA
  • Magnesium
  • Cysteine
Topics
  • Antiviral Agents (chemical synthesis, chemistry, pharmacology)
  • Binding Sites
  • Catalytic Domain
  • Cations, Divalent
  • Cell Line
  • Chelating Agents (chemical synthesis, chemistry, pharmacology)
  • Cysteine (chemistry)
  • DNA (chemistry)
  • HIV Integrase Inhibitors (chemical synthesis, chemistry, pharmacology)
  • HIV-1 (drug effects)
  • Humans
  • Hydrazines (chemical synthesis, chemistry, pharmacology)
  • Magnesium
  • Manganese
  • Models, Molecular
  • Salicylates (chemical synthesis, chemistry, pharmacology)
  • Structure-Activity Relationship
  • Sulfhydryl Compounds (chemical synthesis, chemistry, pharmacology)
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: